Complement and viral pathogenesis

Virology

Volumn 411, Issue 2, 2011, Pages 362-373

  Stoermer, Kristina A ^a   Morrison, Thomas E ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Complement; Pathogenesis; Virus

Indexed keywords

ALPHA INTERFERON; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT COMPONENT C5B; IMMUNOGLOBULIN G; INTERLEUKIN 2; MANNOSE BINDING LECTIN; VIRUS ANTIBODY;

ADAPTIVE IMMUNITY; ALPHA VIRUS; ANTIBODY DEPENDENT ENHANCEMENT; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CYTOKINE PRODUCTION; DENGUE; EBOLA VIRUS; FLAVIVIRUS; HEPATITIS C; HERPES SIMPLEX VIRUS 1; HUMAN; HUMORAL IMMUNITY; IMMUNE EVASION; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; ROSS RIVER ALPHA VIRUS; SARS CORONAVIRUS; SEIZURE; T LYMPHOCYTE ACTIVATION; TH17 CELL; VIRION; VIRUS NEUTRALIZATION; VIRUS PARTICLE; VIRUS PATHOGENESIS; VIRUS VIRULENCE; WEST NILE FLAVIVIRUS;

COMPLEMENT SYSTEM PROTEINS; HUMANS; VIRUS DISEASES; VIRUSES;

EID: 79952073504     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.12.045     Document Type: Review

References (141)

1. Acioli-Santos B., Segat L., Dhalia R., Brito C.A., Braga-Neto U.M., Marques E.T., Crovella S. MBL2 gene polymorphisms protect against development of thrombocytopenia associated with severe dengue phenotype. Hum. Immunol. 2008, 69(2):122-128.
2. Albrecht J.C., Fleckenstein B. New member of the multigene family of complement control proteins in herpesvirus saimiri. J. Virol. 1992, 66(6):3937-3940.
3. Alcon-LePoder S., Sivard P., Drouet M.T., Talarmin A., Rice C., Flamand M. Secretion of flaviviral non-structural protein NS1: from diagnosis to pathogenesis. Novartis Found. Symp. 2006, 277:233-247. discussion 247-53.
4. Alexandre K.B., Gray E.S., Lambson B.E., Moore P.L., Choge I.A., Mlisana K., Karim S.S., McMahon J., O'Keefe B., Chikwamba R., Morris L. Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin. Virology 2010, 402(1):187-196.
5. Auffermann-Gretzinger S., Keeffe E.B., Levy S. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 2001, 97(10):3171-3176.
6. Avirutnan P., Punyadee N., Noisakran S., Komoltri C., Thiemmeca S., Auethavornanan K., Jairungsri A., Kanlaya R., Tangthawornchaikul N., Puttikhunt C., Pattanakitsakul S.N., Yenchitsomanus P.T., Mongkolsapaya J., Kasinrerk W., Sittisombut N., Husmann M., Blettner M., Vasanawathana S., Bhakdi S., Malasit P. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J. Infect. Dis. 2006, 193(8):1078-1088.
7. Avirutnan P., Fuchs A., Hauhart R.E., Somnuke P., Youn S., Diamond M.S., Atkinson J.P. Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. J. Exp. Med. 2010, 207(4):793-806.
8. Awasthi S., Lubinski J.M., Friedman H.M. Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine. Vaccine 2009, 27(49):6845-6853.
9. Bain C., Fatmi A., Zoulim F., Zarski J.P., Trepo C., Inchauspe G. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 2001, 120(2):512-524.
10. Balsitis S.J., Williams K.L., Lachica R., Flores D., Kyle J.L., Mehlhop E., Johnson S., Diamond M.S., Beatty P.R., Harris E. Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog 2010, 6(2):e1000790.
11. Banki Z., Posch W., Ejaz A., Oberhauser V., Willey S., Gassner C., Stoiber H., Dittmer U., Dierich M.P., Hasenkrug K.J., Wilflingseder D. Complement as an endogenous adjuvant for dendritic cell-mediated induction of retrovirus-specific CTLs. PLoS Pathog. 2010, 6(4):e1000891.
12. Beebe D.P., Cooper N.R. Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum. J. Immunol. 1981, 126(4):1562-1568.
13. Bokisch V.A., Muller-Eberhard H.J., Dixon F.J. The role of complement in hemorrhagic shock syndrome (dengue). Trans. Assoc. Am. Physicians 1973, 86:102-110.
14. Bonaparte R.S., Hair P.S., Banthia D., Marshall D.M., Cunnion K.M., Krishna N.K. Human astrovirus coat protein inhibits serum complement activation via C1, the first component of the classical pathway. J. Virol. 2008, 82(2):817-827.
15. Bradbury L.E., Kansas G.S., Levy S., Evans R.L., Tedder T.F. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J. Immunol. 1992, 149(9):2841-2850.
16. Carroll M.C. The complement system in regulation of adaptive immunity. Nat. Immunol. 2004, 5(10):981-986.
17. Chang M.L., Yeh C.T., Lin D.Y., Ho Y.P., Hsu C.M., Bissell D.M. Hepatic inflammation mediated by hepatitis C virus core protein is ameliorated by blocking complement activation. BMC Med. Genomics 2009, 2:51.
18. Charles E.D., Dustin L.B. Hepatitis C virus-induced cryoglobulinemia. Kidney Int. 2009, 76(8):818-824.
19. Chen N., Li G., Liszewski M.K., Atkinson J.P., Jahrling P.B., Feng Z., Schriewer J., Buck C., Wang C., Lefkowitz E.J., Esposito J.J., Harms T., Damon I.K., Roper R.L., Upton C., Buller R.M. Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virology 2005, 340(1):46-63.
20. Chung K.M., Liszewski M.K., Nybakken G., Davis A.E., Townsend R.R., Fremont D.H., Atkinson J.P., Diamond M.S. West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H. Proc. Natl Acad. Sci. USA 2006, 103(50):19111-19116.
21. Churdboonchart V., Bhamarapravati N., Futrakul P. Crossed immunoelectrophoresis for the detection of split products of the third complement in dengue hemorrhagic fever. I. Observations in patients' plasma. Am. J. Trop. Med. Hyg. 1983, 32(3):569-576.
22. + T cells increases during acute hepatitis C virus infection and remains elevated in patients with chronic infection. Clin. Immunol. 2009, 132(3):401-411.
23. Da Costa X.J., Brockman M.A., Alicot E., Ma M., Fischer M.B., Zhou X., Knipe D.M., Carroll M.C. Humoral response to herpes simplex virus is complement-dependent. Proc. Natl Acad. Sci. USA 1999, 96(22):12708-12712.
24. Dammacco F., Sansonno D., Piccoli C., Tucci F.A., Racanelli V. The cryoglobulins: an overview. Eur. J. Clin. Invest. 2001, 31(7):628-638.
25. Dempsey P.W., Allison M.E., Akkaraju S., Goodnow C.C., Fearon D.T. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 1996, 271(5247):348-350.
26. Dolganiuc A., Kodys K., Kopasz A., Marshall C., Mandrekar P., Szabo G. Additive inhibition of dendritic cell allostimulatory capacity by alcohol and hepatitis C is not restored by DC maturation and involves abnormal IL-10 and IL-2 induction. Alcohol. Clin. Exp. Res. 2003, 27(6):1023-1031.
27. Drouin S.M., Corry D.B., Kildsgaard J., Wetsel R.A. Cutting edge: the absence of C3 demonstrates a role for complement in Th2 effector functions in a murine model of pulmonary allergy. J. Immunol. 2001, 167(8):4141-4145.
28. Dunkelberger J.R., Song W.C. Role and mechanism of action of complement in regulating T cell immunity. Mol. Immunol. 2010, 47(13):2176-2186.
29. Ehrenstein M.R., Notley C.A. The importance of natural IgM: scavenger, protector and regulator. Nat. Rev. Immunol. 2010, 10(11):778-786.
30. Ezekowitz R.A., Kuhlman M., Groopman J.E., Byrn R.A. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J. Exp. Med. 1989, 169(1):185-196.
31. Fang Y., Xu C., Fu Y.X., Holers V.M., Molina H. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J. Immunol. 1998, 160(11):5273-5279.
32. Feng J.Q., Mozdzanowska K., Gerhard W. Complement component C1q enhances the biological activity of influenza virus hemagglutinin-specific antibodies depending on their fine antigen specificity and heavy-chain isotype. J. Virol. 2002, 76(3):1369-1378.
33. Fernandez Gonzalez S., Jayasekera J.P., Carroll M.C. Complement and natural antibody are required in the long-term memory response to influenza virus. Vaccine 2008, 26(Suppl 8):I86-I93.
34. Friedman H.M., Cohen G.H., Eisenberg R.J., Seidel C.A., Cines D.B. Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells. Nature 1984, 309(5969):633-635.
35. Friedman H.M., Wang L., Fishman N.O., Lambris J.D., Eisenberg R.J., Cohen G.H., Lubinski J. Immune evasion properties of herpes simplex virus type 1 glycoprotein gC. J. Virol. 1996, 70(7):4253-4260.
36. Fries L.F., Friedman H.M., Cohen G.H., Eisenberg R.J., Hammer C.H., Frank M.M. Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade. J. Immunol. 1986, 137(5):1636-1641.
37. Fuchs A., Lin T.Y., Beasley D.W., Stover C.M., Schwaeble W.J., Pierson T.C., Diamond M.S. Direct complement restriction of flavivirus infection requires glycan recognition by mannose-binding lectin. Cell Host Microbe 2010, 8(2):186-195.
38. Fujita T. Evolution of the lectin-complement pathway and its role in innate immunity. Nat. Rev. Immunol. 2002, 2(5):346-353.
39. Gonzalez S.F., Lukacs-Kornek V., Kuligowski M.P., Pitcher L.A., Degn S.E., Turley S.J., Carroll M.C. Complement-dependent transport of antigen into B cell follicles. J. Immunol. 2010, 185(5):2659-2664.
40. Gros P., Milder F.J., Janssen B.J. Complement driven by conformational changes. Nat. Rev. Immunol. 2008, 8(1):48-58.
41. Hair P.S., Gronemus J.Q., Crawford K.B., Salvi V.P., Cunnion K.M., Thielens N.M., Arlaud G.J., Rawal N., Krishna N.K. Human astrovirus coat protein binds C1q and MBL and inhibits the classical and lectin pathways of complement activation. Mol. Immunol. 2010, 47(4):792-798.
42. Hajishengallis G., Lambris J.D. Crosstalk pathways between Toll-like receptors and the complement system. Trends Immunol. 2010, 31(4):154-163.
43. Harris S.L., Frank I., Yee A., Cohen G.H., Eisenberg R.J., Friedman H.M. Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization. J. Infect. Dis. 1990, 162(2):331-337.
44. Hebell T., Ahearn J.M., Fearon D.T. Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science 1991, 254(5028):102-105.
45. Heyman B., Wiersma E.J., Kinoshita T. In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody. J. Exp. Med. 1990, 172(2):665-668.
46. Hidaka Y., Sakai Y., Toh Y., Mori R. Glycoprotein C of herpes simplex virus type 1 is essential for the virus to evade antibody-independent complement-mediated virus inactivation and lysis of virus-infected cells. J. Gen. Virol. 1991, 72(Pt 4):915-921.
47. Hillebrandt S., Goos C., Matern S., Lammert F. Genome-wide analysis of hepatic fibrosis in inbred mice identifies the susceptibility locus Hfib1 on chromosome 15. Gastroenterology 2002, 123(6):2041-2051.
48. Hillebrandt S., Wasmuth H.E., Weiskirchen R., Hellerbrand C., Keppeler H., Werth A., Schirin-Sokhan R., Wilkens G., Geier A., Lorenzen J., Kohl J., Gressner A.M., Matern S., Lammert F. Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans. Nat. Genet. 2005, 37(8):835-843.
49. Holers V.M. The complement system as a therapeutic target in autoimmunity. Clin. Immunol. 2003, 107(3):140-151.
50. Hook L.M., Lubinski J.M., Jiang M., Pangburn M.K., Friedman H.M. Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody. J. Virol. 2006, 80(8):4038-4046.
51. Hoorelbeke B., Huskens D., Ferir G., Francois K.O., Takahashi A., Van Laethem K., Schols D., Tanaka H., Balzarini J. Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope. Antimicrob. Agents Chemother. 2010, 54(8):3287-3301.
52. Huber-Lang M., Sarma J.V., Zetoune F.S., Rittirsch D., Neff T.A., McGuire S.R., Lambris J.D., Warner R.L., Flierl M.A., Hoesel L.M., Gebhard F., Younger J.G., Drouin S.M., Wetsel R.A., Ward P.A. Generation of C5a in the absence of C3: a new complement activation pathway. Nat. Med. 2006, 12(6):682-687.
53. Hung S.L., Peng C., Kostavasili I., Friedman H.M., Lambris J.D., Eisenberg R.J., Cohen G.H. The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway. Virology 1994, 203(2):299-312.
54. Huskens D., Ferir G., Vermeire K., Kehr J.C., Balzarini J., Dittmann E., Schols D. Microvirin, a novel alpha(1, 2)-mannose-specific lectin isolated from Microcystis aeruginosa, has anti-HIV-1 activity comparable with that of cyanovirin-N but a much higher safety profile. J. Biol. Chem. 2010, 285(32):24845-24854.
55. Ip W.K., Chan K.H., Law H.K., Tso G.H., Kong E.K., Wong W.H., To Y.F., Yung R.W., Chow E.Y., Au K.L., Chan E.Y., Lim W., Jensenius J.C., Turner M.W., Peiris J.S., Lau Y.L. Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. J. Infect. Dis. 2005, 191(10):1697-1704.
56. Isaacs S.N., Kotwal G.J., Moss B. Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc. Natl Acad. Sci. USA 1992, 89(2):628-632.
57. Jayasekera J.P., Moseman E.A., Carroll M.C. Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity. J. Virol. 2007, 81(7):3487-3494.
58. Ji X., Gewurz H., Spear G.T. Mannose binding lectin (MBL) and HIV. Mol. Immunol. 2005, 42(2):145-152.
59. Ji X., Olinger G.G., Aris S., Chen Y., Gewurz H., Spear G.T. Mannose-binding lectin binds to Ebola and Marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complement-mediated virus neutralization. J. Gen. Virol. 2005, 86(Pt 9):2535-2542.
60. Johnson J.B., Capraro G.A., Parks G.D. Differential mechanisms of complement-mediated neutralization of the closely related paramyxoviruses simian virus 5 and mumps virus. Virology 2008, 376(1):112-123.
61. Johnson J.B., Grant K., Parks G.D. The paramyxoviruses simian virus 5 and mumps virus recruit host cell CD46 to evade complement-mediated neutralization. J. Virol. 2009, 83(15):7602-7611.
62. Joubert P.E., Meiffren G., Gregoire I.P., Pontini G., Richetta C., Flacher M., Azocar O., Vidalain P.O., Vidal M., Lotteau V., Codogno P., Rabourdin-Combe C., Faure M. Autophagy induction by the pathogen receptor CD46. Cell Host Microbe 2009, 6(4):354-366.
63. Kakumu S., Ito S., Ishikawa T., Mita Y., Tagaya T., Fukuzawa Y., Yoshioka K. Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection. J. Gastroenterol. Hepatol. 2000, 15(4):431-436.
64. Kang Y.S., Do Y., Lee H.K., Park S.H., Cheong C., Lynch R.M., Loeffler J.M., Steinman R.M., Park C.G. A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q. Cell 2006, 125(1):47-58.
65. Kanto T., Hayashi N., Takehara T., Tatsumi T., Kuzushita N., Ito A., Sasaki Y., Kasahara A., Hori M. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J. Immunol. 1999, 162(9):5584-5591.
66. Kanto T., Inoue M., Miyatake H., Sato A., Sakakibara M., Yakushijin T., Oki C., Itose I., Hiramatsu N., Takehara T., Kasahara A., Hayashi N. Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J. Infect. Dis. 2004, 190(11):1919-1926.
67. Kapadia S.B., Molina H., van Berkel V., Speck S.H., Virgin H.W.t. Murine gammaherpesvirus 68 encodes a functional regulator of complement activation. J. Virol. 1999, 73(9):7658-7670.
68. Kapadia S.B., Levine B., Speck S.H., Virgin H.W.t. Critical role of complement and viral evasion of complement in acute, persistent, and latent gamma-herpesvirus infection. Immunity 2002, 17(2):143-155.
69. Kemper C., Atkinson J.P. T-cell regulation: with complements from innate immunity. Nat. Rev. Immunol. 2007, 7(1):9-18.
70. + cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003, 421(6921):388-392.
71. Kemper C., Atkinson J.P., Hourcade D.E. Properdin: emerging roles of a pattern-recognition molecule. Annu. Rev. Immunol. 2010, 28:131-155.
72. + T cell responses. J. Immunol. 2004, 173(4):2524-2529.
73. Kittlesen D.J., Chianese-Bullock K.A., Yao Z.Q., Braciale T.J., Hahn Y.S. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J. Clin. Invest. 2000, 106(10):1239-1249.
74. Kopf M., Abel B., Gallimore A., Carroll M., Bachmann M.F. Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection. Nat. Med. 2002, 8(4):373-378.
75. Kostavasili I., Sahu A., Friedman H.M., Eisenberg R.J., Cohen G.H., Lambris J.D. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus. J. Immunol. 1997, 158(4):1763-1771.
76. Kurosu T., Chaichana P., Yamate M., Anantapreecha S., Ikuta K. Secreted complement regulatory protein clusterin interacts with dengue virus nonstructural protein 1. Biochem. Biophys. Res. Commun. 2007, 362(4):1051-1056.
77. Kyle J.L., Harris E. Global spread and persistence of dengue. Annu. Rev. Microbiol. 2008, 62:71-92.
78. Lajoie S., Lewkowich I.P., Suzuki Y., Clark J.R., Sproles A.A., Dienger K., Budelsky A.L., Wills-Karp M. Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat. Immunol. 2010, 11(10):928-935.
79. Large M.K., Kittlesen D.J., Hahn Y.S. Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence. J. Immunol. 1999, 162(2):931-938.
80. Li W., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., Somasundaran M., Sullivan J.L., Luzuriaga K., Greenough T.C., Choe H., Farzan M. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003, 426(6965):450-454.
81. Libbey J.E., Kirkman N.J., Smith M.C., Tanaka T., Wilcox K.S., White H.S., Fujinami R.S. Seizures following picornavirus infection. Epilepsia 2008, 49(6):1066-1074.
82. Libbey J.E., Kirkman N.J., Wilcox K.S., White H.S., Fujinami R.S. Role for complement in the development of seizures following acute viral infection. J. Virol. 2010, 84(13):6452-6460.
83. Libraty D.H., Young P.R., Pickering D., Endy T.P., Kalayanarooj S., Green S., Vaughn D.W., Nisalak A., Ennis F.A., Rothman A.L. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J. Infect. Dis. 2002, 186(8):1165-1168.
84. Liszewski M.K., Leung M.K., Hauhart R., Buller R.M., Bertram P., Wang X., Rosengard A.M., Kotwal G.J., Atkinson J.P. Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation. J. Immunol. 2006, 176(6):3725-3734.
85. + T cell activity in a complement-independent manner. J. Immunol. 2005, 175(11):7098-7102.
86. Lubinski J.M., Wang L., Soulika A.M., Burger R., Wetsel R.A., Colten H., Cohen G.H., Eisenberg R.J., Lambris J.D., Friedman H.M. Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo. J. Virol. 1998, 72(10):8257-8263.
87. Lubinski J., Wang L., Mastellos D., Sahu A., Lambris J.D., Friedman H.M. In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC. J. Exp. Med. 1999, 190(11):1637-1646.
88. Lubinski J.M., Jiang M., Hook L., Chang Y., Sarver C., Mastellos D., Lambris J.D., Cohen G.H., Eisenberg R.J., Friedman H.M. Herpes simplex virus type 1 evades the effects of antibody and complement in vivo. J. Virol. 2002, 76(18):9232-9241.
89. Madsen H.O., Garred P., Thiel S., Kurtzhals J.A., Lamm L.U., Ryder L.P., Svejgaard A. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J. Immunol. 1995, 155(6):3013-3020.
90. Maillard P., Krawczynski K., Nitkiewicz J., Bronnert C., Sidorkiewicz M., Gounon P., Dubuisson J., Faure G., Crainic R., Budkowska A. Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients. J. Virol. 2001, 75(17):8240-8250.
91. Marie J.C., Astier A.L., Rivailler P., Rabourdin-Combe C., Wild T.F., Horvat B. Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell induced inflammation. Nat. Immunol. 2002, 3(7):659-666.
92. Markiewski M.M., Nilsson B., Ekdahl K.N., Mollnes T.E., Lambris J.D. Complement and coagulation: strangers or partners in crime?. Trends Immunol. 2007, 28(4):184-192.
93. Markiewski M.M., DeAngelis R.A., Benencia F., Ricklin-Lichtsteiner S.K., Koutoulaki A., Gerard C., Coukos G., Lambris J.D. Modulation of the antitumor immune response by complement. Nat. Immunol. 2008, 9(11):1225-1235.
94. Matsumoto M., Fukuda W., Circolo A., Goellner J., Strauss-Schoenberger J., Wang X., Fujita S., Hidvegi T., Chaplin D.D., Colten H.R. Abrogation of the alternative complement pathway by targeted deletion of murine factor B. Proc. Natl Acad. Sci. USA 1997, 94(16):8720-8725.
95. Mehlhop E., Diamond M.S. Protective immune responses against West Nile virus are primed by distinct complement activation pathways. J. Exp. Med. 2006, 203(5):1371-1381.
96. Mehlhop E., Whitby K., Oliphant T., Marri A., Engle M., Diamond M.S. Complement activation is required for induction of a protective antibody response against West Nile virus infection. J. Virol. 2005, 79(12):7466-7477.
97. Mehlhop E., Ansarah-Sobrinho C., Johnson S., Engle M., Fremont D.H., Pierson T.C., Diamond M.S. Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner. Cell Host Microbe 2007, 2(6):417-426.
98. Mehlhop E., Nelson S., Jost C.A., Gorlatov S., Johnson S., Fremont D.H., Diamond M.S., Pierson T.C. Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization of West Nile virus. Cell Host Microbe 2009, 6(4):381-391.
99. Moorman J., Saad M., Kosseifi S., Krishnaswamy G. Hepatitis C virus and the lung: implications for therapy. Chest 2005, 128(4):2882-2892.
100. Moorman J.P., Fitzgerald S.M., Prayther D.C., Lee S.A., Chi D.S., Krishnaswamy G. Induction of p38- and gC1qR-dependent IL-8 expression in pulmonary fibroblasts by soluble hepatitis C core protein. Respir. Res. 2005, 6:105.
101. Morrison T.E., Fraser R.J., Smith P.N., Mahalingam S., Heise M.T. Complement contributes to inflammatory tissue destruction in a mouse model of Ross River virus-induced disease. J. Virol. 2007, 81(10):5132-5143.
102. Morrison T.E., Simmons J.D., Heise M.T. Complement receptor 3 promotes severe ross river virus-induced disease. J. Virol. 2008, 82(22):11263-11272.
103. Moulton E.A., Atkinson J.P., Buller R.M. Surviving mousepox infection requires the complement system. PLoS Pathog. 2008, 4(12):e1000249.
104. Moulton E.A., Bertram P., Chen N., Buller R.M., Atkinson J.P. Ectromelia virus inhibitor of complement enzymes protects intracellular mature virus and infected cells from mouse complement. J. Virol. 2010, 84(18):9128-9139.
105. Mozdzanowska K., Feng J., Eid M., Zharikova D., Gerhard W. Enhancement of neutralizing activity of influenza virus-specific antibodies by serum components. Virology 2006, 352(2):418-426.
106. Mullick J., Bernet J., Singh A.K., Lambris J.D., Sahu A. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) open reading frame 4 protein (kaposica) is a functional homolog of complement control proteins. J. Virol. 2003, 77(6):3878-3881.
107. Mullick J., Kadam A., Sahu A. Herpes and pox viral complement control proteins: 'the mask of self'. Trends Immunol. 2003, 24(9):500-507.
108. Nascimento E.J., Silva A.M., Cordeiro M.T., Brito C.A., Gil L.H., Braga-Neto U., Marques E.T. Alternative complement pathway deregulation is correlated with dengue severity. PLoS ONE 2009, 4(8):e6782.
109. Ochsenbein A.F., Zinkernagel R.M. Natural antibodies and complement link innate and acquired immunity. Immunol. Today 2000, 21(12):624-630.
110. Ochsenbein A.F., Fehr T., Lutz C., Suter M., Brombacher F., Hengartner H., Zinkernagel R.M. Control of early viral and bacterial distribution and disease by natural antibodies. Science 1999, 286(5447):2156-2159.
111. Ochsenbein A.F., Pinschewer D.D., Odermatt B., Carroll M.C., Hengartner H., Zinkernagel R.M. Protective T cell-independent antiviral antibody responses are dependent on complement. J. Exp. Med. 1999, 190(8):1165-1174.
112. Ricklin D., Hajishengallis G., Yang K., Lambris J.D. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 2010, 11(9):785-797.
113. Rosengard A.M., Liu Y., Nie Z., Jimenez R. Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement. Proc. Natl Acad. Sci. USA 2002, 99(13):8808-8813.
114. Sahu A., Isaacs S.N., Soulika A.M., Lambris J.D. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway. J. Immunol. 1998, 160(11):5596-5604.
115. Saifuddin M., Parker C.J., Peeples M.E., Gorny M.K., Zolla-Pazner S., Ghassemi M., Rooney I.A., Atkinson J.P., Spear G.T. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1. J. Exp. Med. 1995, 182(2):501-509.
116. Saifuddin M., Hart M.L., Gewurz H., Zhang Y., Spear G.T. Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1. J. Gen. Virol. 2000, 81(Pt 4):949-955.
117. Sansonno D., Lauletta G., Nisi L., Gatti P., Pesola F., Pansini N., Dammacco F. Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia. Clin. Exp. Immunol. 2003, 133(2):275-282.
118. Sansonno D., Tucci F.A., Ghebrehiwet B., Lauletta G., Peerschke E.I., Conteduca V., Russi S., Gatti P., Sansonno L., Dammacco F. Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damage. J. Immunol. 2009, 183(9):6013-6020.
119. Spear G.T., Lurain N.S., Parker C.J., Ghassemi M., Payne G.H., Saifuddin M. Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV). J. Immunol. 1995, 155(9):4376-4381.
120. Spiller O.B., Robinson M., O'Donnell E., Milligan S., Morgan B.P., Davison A.J., Blackbourn D.J. Complement regulation by Kaposi's sarcoma-associated herpesvirus ORF4 protein. J. Virol. 2003, 77(1):592-599.
121. Suresh M., Molina H., Salvato M.S., Mastellos D., Lambris J.D., Sandor M. Complement component 3 is required for optimal expansion of CD8 T cells during a systemic viral infection. J. Immunol. 2003, 170(2):788-794.
122. Takada A., Kawaoka Y. Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications. Rev. Med. Virol. 2003, 13(6):387-398.
123. Takada A., Feldmann H., Ksiazek T.G., Kawaoka Y. Antibody-dependent enhancement of Ebola virus infection. J. Virol. 2003, 77(13):7539-7544.
124. Tal-Singer R., Seidel-Dugan C., Fries L., Huemer H.P., Eisenberg R.J., Cohen G.H., Friedman H.M. Herpes simplex virus glycoprotein C is a receptor for complement component iC3b. J. Infect. Dis. 1991, 164(4):750-753.
125. Tsuji R.F., Kawikova I., Ramabhadran R., Akahira-Azuma M., Taub D., Hugli T.E., Gerard C., Askenase P.W. Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment. J. Immunol. 2000, 165(3):1588-1598.
126. Verschoor A., Brockman M.A., Knipe D.M., Carroll M.C. Cutting edge: myeloid complement C3 enhances the humoral response to peripheral viral infection. J. Immunol. 2001, 167(5):2446-2451.
127. Verschoor A., Brockman M.A., Gadjeva M., Knipe D.M., Carroll M.C. Myeloid C3 determines induction of humoral responses to peripheral herpes simplex virus infection. J. Immunol. 2003, 171(10):5363-5371.
128. Virgin H.W.t., Latreille P., Wamsley P., Hallsworth K., Weck K.E., Dal Canto A.J., Speck S.H. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 1997, 71(8):5894-5904.
129. + T cells via suppression of dendritic cell IL-12 production. J. Leukoc. Biol. 2007, 82(6):1407-1419.
130. Wagner C., Ochmann C., Schoels M., Giese T., Stegmaier S., Richter R., Hug F., Hansch G.M. The complement receptor 1, CR1 (CD35), mediates inhibitory signals in human T-lymphocytes. Mol. Immunol. 2006, 43(6):643-651.
131. Yamanaka A., Kosugi S., Konishi E. Infection-enhancing and -neutralizing activities of mouse monoclonal antibodies against dengue type 2 and 4 viruses are controlled by complement levels. J. Virol. 2008, 82(2):927-937.
132. Yang Z.Y., Huang Y., Ganesh L., Leung K., Kong W.P., Schwartz O., Subbarao K., Nabel G.J. pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J. Virol. 2004, 78(11):5642-5650.
133. Yao Z.Q., Nguyen D.T., Hiotellis A.I., Hahn Y.S. Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway. J. Immunol. 2001, 167(9):5264-5272.
134. Yao Z.Q., Prayther D., Trabue C., Dong Z.P., Moorman J. Differential regulation of SOCS-1 signalling in B and T lymphocytes by hepatitis C virus core protein. Immunology 2008, 125(2):197-207.
135. Ying H., Ji X., Hart M.L., Gupta K., Saifuddin M., Zariffard M.R., Spear G.T. Interaction of mannose-binding lectin with HIV type 1 is sufficient for virus opsonization but not neutralization. AIDS Res. Hum. Retroviruses 2004, 20(3):327-335.
136. Yuan F.F., Tanner J., Chan P.K., Biffin S., Dyer W.B., Geczy A.F., Tang J.W., Hui D.S., Sung J.J., Sullivan J.S. Influence of FcgammaRIIA and MBL polymorphisms on severe acute respiratory syndrome. Tissue Antigens 2005, 66(4):291-296.
137. Zellweger R.M., Prestwood T.R., Shresta S. Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host Microbe 2010, 7(2):128-139.
138. Zhang H., Zhou G., Zhi L., Yang H., Zhai Y., Dong X., Zhang X., Gao X., Zhu Y., He F. Association between mannose-binding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection. J. Infect. Dis. 2005, 192(8):1355-1361.
139. Zhang J., Li G., Liu X., Wang Z., Liu W., Ye X. Influenza A virus M1 blocks the classical complement pathway through interacting with C1qA. J. Gen. Virol. 2009, 90(Pt 11):2751-2758.
140. Zhou Y., Lu K., Pfefferle S., Bertram S., Glowacka I., Drosten C., Pohlmann S., Simmons G. A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms. J. Virol. 2010, 84(17):8753-8764.
141. Zipfel P.F., Skerka C. Complement regulators and inhibitory proteins. Nat. Rev. Immunol. 2009, 9(10):729-740.